Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study

Naval Daver, Pau Montesinos, Daniel J. DeAngelo, Eunice S. Wang, Nikolaos Papadantonakis, Elisabetta Todisco, Kendra Sweet, Naveen Pemmaraju, Andrew A. Lane, Laura Torres-Miñana, James E. Thompson, Marina Konopleva, Callum M. Sloss, Krystal Watkins, Gaurav Bedse, Yining Du, Kara E Malcolm, Patrick A. Zweidler‐McKay, Hagop M. Kantarjian